Publications:  Dr Maria Niklison-Chirou

Fafián-Labora J, Carpintero-Fernández P, Jordan SJD, Shikh-Bahaei T, Abdullah SM, Mahenthiran M, Rodríguez-Navarro JA, Niklison-Chirou MV et al.(2019). FASN activity is important for the initial stages of the induction of senescence. Cell Death Dis vol. 10, (4)

Rotblat B, Agostini M, NIKLISON-CHIROU MV, Amelio I, Willis AE, Melino G(2018). Sustained protein synthesis and reduced eEF2K levels in TAp73-\- mice brain: a possible compensatory mechanism. Cell Cycle vol. 17, (23) 2637-2643.

Marini A, Rotblat B, Sbarrato T, Niklison-Chirou MV, Knight JRP, Dudek K, Jones C, Bushell M et al.(2018). TAp73 contributes to the oxidative stress response by regulating protein synthesis. Proceedings of the National Academy of Sciences vol. 115, (24) 6219-6224.

Agostini M, Niklison-Chirou MV, Annicchiarico-Petruzzelli MM, Grelli S, Di Daniele N, Pestlikis I, Knight RA, Melino G et al.(2018). p73 Regulates Primary Cortical Neuron Metabolism: a Global Metabolic Profile. Molecular Neurobiology vol. 55, (4) 3237-3250.

Niklison-Chirou MV(2018). Glutamine metabolism, the Achilles heel for medulloblastoma tumor. Cell Death & Disease vol. 9, (2) Article 75,

Niklison-Chirou MV, Erngren I, Engskog M, Haglöf J, Picard D, Remke M, McPolin P, Selby M et al.(2017). TAp73 is a marker of glutamine addiction in medulloblastoma. Genes and Development

MARINO S, Dibenedetto S, Niklison-Chirou M, Cabrera C, Ellis M, Robson LG, Knopp P, Barnes M et al.(2017). Enhanced energetic state and protection from oxidative stress in human myoblasts overexpressing BMI1. Stem Cell Reports

Niklison-Chirou MV, Killick R, Knight RA, Nicotera P, Melino G, Agostini M(2016). How Does p73 Cause Neuronal Defects?. Molecular Neurobiology vol. 53, (7) 4509-4520.

Agostini M, Romeo F, Inoue S, Niklison-Chirou MV, Elia AJ, Dinsdale D, Morone N, Knight RA et al.(2016). Metabolic reprogramming during neuronal differentiation. Cell Death Differ vol. 23, (9) 1502-1514.

Agostini M, Niklison-Chirou MV, Catani MV, Knight RA, Melino G, Rufini A(2014). TAp73 promotes anti-senescence-anabolism not proliferation. Aging vol. 6, (11) 921-930.

Niklison-Chirou MV, Steinert JR, Agostini M, Knight RA, Dinsdale D, Cattaneo A, Mak TW, Melino G(2013). TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor. Proceedings of the National Academy of Sciences vol. 110, (47) 18952-18957.